News

Barchart on MSN7h
2 ‘Strong Buy’ Stocks to Buy on Plans to Increase American Manufacturing
President Donald Trump’s tariffs have two primary objectives. One is to rebalance the world trade order, which he believes is ...
Econostrum on MSN9h
US Pharmaceutical Tariffs Could Raise Drug Prices by $51 Billion Annually, Report Finds
A 25% tariff proposed on pharmaceutical imports could significantly impact U.S. drug prices, raising overall costs by nearly ...
Novo Nordisk: Examining Tariff And Pricing Risks
Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...
Say goodbye to cheap versions of Ozempic and Wegovy
This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...
News-Medical.Net19h
New method improves RMST analysis for clinical and epidemiological studies
The restricted mean survival time (RMST) analysis technique was introduced in health care research about 25 years ago and since then has become widely used in economics, engineering, business and ...
Prep roundup: Braeden Parker hits four RBIs for Mt. Spokane baseball; Lilly Triplett drives in six for Ridgeline softball
Roundup of Friday's high school sports action from the Greater Spokane League. Softball GSL 4A/3A Ridgeline 18, Central Valley 2 (5): Lilly Triplett went 4 for 5 with a home run, double, six RBIs and ...
The Manila Times23h
Innovent Announces NMPA Approval of Limertinib, a Third-generation EGFR TKI Collaborated with ASK Pharma, for the First-line Treatment of Lung Cancer
Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...